Pfizer Patent Right definition

Pfizer Patent Right means any Patent Right comprised in the Pfizer Technology.
View Source
Pfizer Patent Right means any Patent Right that (a) is Controlled by Pfizer or any of its Affiliates on the Effective Date or that comes into the Control of Pfizer or any of its Affiliates during the Term (other than through the grant of a license by BioNTech), including Pfizer’s rights in any Research Program Patent Rights, and (b) claims any (i) Candidate or Product (including the composition of matter thereof), (ii) method of making any Candidate or Product, (iii) methods of using any Candidate or Product or (iv) Pfizer Know-How.
View Source
Pfizer Patent Right means any Patent Right that (i) is Controlled by Pfizer on the Effective Date or that comes into the Control of Pfizer during the Term (other than through the grant of a license by Valneva) or (ii) is conceived, discovered, developed or otherwise made, by or on behalf of Pfizer (other than by or on behalf of Valneva) under this Agreement and, in each of (i) and (ii), claims any (w) Vaccine or Product (including the composition of matter thereof), (x) method of making any Vaccine or Product, (y) methods of using any Vaccine or Product or (z) Pfizer Know-How.
View Source

Examples of Pfizer Patent Right in a sentence

  • Pfizer will have the sole right, but no obligation, to take action to obtain a discontinuance of infringement or bring suit against a Third Party infringing or challenging the validity or enforceability of any Pfizer Patent Right.

  • Pfizer, at its own expense, shall have the sole right, but not the obligation, to prepare, file, prosecute and maintain, throughout the world, any Pfizer Patent Right other than any Agreement T-DART Patent Right.

  • Pfizer shall have the sole right, but not the obligation, to institute litigation or take other steps to remedy infringement in connection with any field in respect of any Patent Rights that it solely owns including any Pfizer Patent Right.

  • Subject to Sections 7.3.2(b) and 7.3.2(c), Pfizer shall have the sole right, but no obligation, to institute litigation or take other steps to remedy infringement in connection with in any field in respect of any Patent Rights that it solely owns including any Pfizer Patent Right.

  • Upon the giving or receipt of such notice, Pfizer will have the sole right, but not the obligation, to bring an infringement action against such Third Party with respect to any eFFECTOR Product-Specific Patent Right, Joint Patent Right or Pfizer Patent Right (in a manner consistent with Section 6.3.2(a) or 6.3.2(c)).

  • Pfizer shall have the sole right, but no obligation, to take action to obtain a discontinuance of infringement or bring suit against a Third Party infringing or challenging the validity or enforceability of any Pfizer Patent Right or any Sponsored Research Patent Right.

  • Each of the Parties shall promptly notify the other in the event of any potential infringement by any Third Party of an Incyte Product Patent Right, Incyte Program Patent Right, Incyte Patent Right, Program Patent Right, Pfizer Patent Right, Pfizer Process Patent Claim or Pfizer Use Patent Claim of which it becomes aware.

  • Pfizer will have the sole right, but no obligation, to take action to obtain a discontinuance of infringement or bring suit against a Third Party infringing or challenging the validity or enforceability of any Pfizer Patent Right or Development Patent Right.

  • Pfizer shall have no obligation to apply any particular Pfizer Know-How, Pfizer Patent Right or other technology owned by Pfizer or which Pfizer has the right to use in connection with the Manufacture of any Product hereunder or in the development of any process for the Manufacture of any Product hereunder.

  • Notwithstanding anything to the contrary in this Agreement, Pfizer shall have no obligation to apply any particular Pfizer Know-How, Pfizer Patent Right or [*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.


More Definitions of Pfizer Patent Right

Pfizer Patent Right means any Patent Right that (a) is Controlled by Pfizer or any of its Affiliates as of the Effective Date or (b) that comes into the Control of Pfizer or any of its Affiliates during the Term (other than through the grant of a license by Codex) and, in each case ((a) and (b)), claims or discloses any invention included in any Pfizer Know-How. 1.1.68. “Pfizer Quarter” means each of the four (4) thirteen (13) week periods (a) with respect to the United States, commencing on January 1 of any Pfizer Year and (b) with respect to any country in the Territory other than the United States, commencing on December 1 of any Pfizer Year. 1.1.69. “Pfizer Sole Research Plan Know-How” means any (a) Research Plan Know-How that is invented solely by or on behalf of Pfizer or its Affiliates in the course of performing activities under the Research Plan, (b) any Pfizer Material Improvement and (c) any Output Materials Know-How. 1.1.70. “Pfizer Sole Research Plan Patent Right” means any Patent Right that claims or discloses any invention included in any Pfizer Sole Research Plan Know-How. All Pfizer Material Improvement and Output Material Patent Rights will be Pfizer Sole Research Plan Patent Rights. 1.1.71. “Pfizer Technology” means the Pfizer Know-How and Pfizer Patent Rights. 1.1.72. “Pfizer Year” means the twelve-month fiscal periods observed by Pfizer (a) commencing on January 1 with respect to the United States and (b) commencing on December 1 with respect to any country in the Territory other than the United States.
View Source

Related to Pfizer Patent Right

  • Patent Right means: (a) an issued or granted patent, including any extension, supplemental protection certificate, registration, confirmation, reissue, reexamination, extension or renewal thereof; (b) a pending patent application, including any continuation, divisional, continuation-in-part, substitute or provisional application thereof; and (c) all counterparts or foreign equivalents of any of the foregoing issued by or filed in any country or other jurisdiction.

  • Licensed Patent Rights means: (a) Patent applications (including provisional patent applications and PCT patent applications) or patents listed in Appendix A, all divisions and continuations of these applications, all patents issuing from these applications, divisions, and continuations, and any reissues, reexaminations, and extensions of these patents; (b) to the extent that the following contain one or more claims directed to the invention or inventions disclosed in 2.9(a): (i) continuations-in-part of 2.9(a); (ii) all divisions and continuations of these continuations-in-part; (iii) all patents issuing from these continuations-in-part, divisions, and continuations; (iv) priority patent application(s) of 2.9(a); and (v) any reissues, reexaminations, and extensions of these patents; (c) to the extent that the following contain one or more claims directed to the invention or inventions disclosed in 2.9(a): all counterpart foreign and U.S. patent applications and patents to 2.9(a) and 2.9(b), including those listed in Appendix A; and (d) Licensed Patent Rights shall not include 2.9(b) or 2.9(c) to the extent that they contain one or more claims directed to new matter which is not the subject matter disclosed in 2.9(a).

  • Joint Patent Rights means all Patent Rights claiming a Joint Invention.

  • Program Patent Rights means any Patent Rights that contain one or more claims that cover Program Inventions.

  • Collaboration Patent Rights means Patent Rights claiming Collaboration Know-How.